The use of endpoints in phase 3 randomized controlled trials in metastatic breast cancer. Kupis W, Klosowska D, Harhala M, Sekula M, et al. Breast Cancer Res Treat 2026;217:6.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kupis W, Klosowska D, Harhala M, Sekula M, et al. The use of endpoints in phase 3 randomized controlled trials in metastatic breast cancer. Breast Cancer Res Treat 2026;217:6.
PMID: 41915264